Provided by Tiger Trade Technology Pte. Ltd.

Tenax Therapeutics

1.80
-0.0400-2.17%
Pre-market: 1.830.0300+1.67%06:00 EDT
Volume:4.30M
Turnover:7.77M
Market Cap:67.36M
PE:-1.23
High:1.85
Open:1.79
Low:1.77
Close:1.84
52wk High:19.40
52wk Low:1.31
Shares:37.42M
Float Shares:17.52M
Volume Ratio:0.51
T/O Rate:24.54%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4685
EPS(LYR):-1.3412
ROE:-59.80%
ROA:-37.70%
PB:0.59
PE(LYR):-1.34

Loading ...

Analysts Offer Insights on Healthcare Companies: Dianthus Therapeutics (DNTH), Tenax Therapeutics (TENX) and Compass Therapeutics (CMPX)

TIPRANKS
·
May 10

Tenax Therapeutics awards inducement options for 657,500 shares to new hires

Reuters
·
May 09

Tenax Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
May 09

Tenax Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
May 09

Tenax Therapeutics appoints Timothy Healey chief commercial officer

Reuters
·
May 04

Tenax Therapeutics Names New CFO to Support Growth

TIPRANKS
·
Apr 22

Tenax Therapeutics announces annual shareholder meeting

Reuters
·
Apr 22

Tenax Therapeutics names Thomas R. Staab CFO, replacing interim CFO Thomas McGauley

Reuters
·
Apr 22

Tenax Therapeutics Inc - Thomas R. Staab, Ii Replaces Thomas Mcgauley as CFO

THOMSON REUTERS
·
Apr 22

Tenax Therapeutics Appoints Thomas R. Staab, Ii as Chief Financial Officer

THOMSON REUTERS
·
Apr 22

Press Release: Tenax Therapeutics Appoints Thomas R. Staab, II as Chief Financial Officer

Dow Jones
·
Apr 22

Tenex.ai Raises $250 Million in Funding Round Reportedly Valuing Company at $1 Billion

MT Newswires Live
·
Mar 31

Analysts Offer Insights on Healthcare Companies: Butterfly Network (BFLY) and Tenax Therapeutics (TENX)

TIPRANKS
·
Mar 30

Tenax Therapeutics Files $300 Million Mixed Shelf

MT Newswires Live
·
Mar 25

Tenax Therapeutics files $300M mixed securities shelf

TIPRANKS
·
Mar 24

Tenax Therapeutics Inc - May Offer up to $300 Mln of Securities - SEC Filing

THOMSON REUTERS
·
Mar 24

Tenax Therapeutics Initiated at Overweight by Cantor Fitzgerald

Dow Jones
·
Mar 17

Cantor starts Tenax at Overweight into Phase 3 readout

TIPRANKS
·
Mar 17

Cantor Fitzgerald Initiates Tenax Therapeutics at Overweight With $35 Price Target

MT Newswires Live
·
Mar 17

Tenax Therapeutics Is Maintained at Buy by Guggenheim

Dow Jones
·
Mar 16